Robotic Lobectomy for Lung Cancer

(OTC-RATS Trial)

This trial explores a new method for performing lung cancer surgery using a robotic system. It focuses on testing the safety and feasibility of this approach for patients with small, early-stage lung tumors. The trial seeks participants who already have lung cancer surgery planned at CHUM using minimally invasive techniques. Eligible participants should have early-stage lung cancer and be scheduled for a specific type of surgery, either a VATS (Video-Assisted Thoracoscopic Surgery) or RATS (Robotic-Assisted Thoracoscopic Surgery) lobectomy. As an unphased trial, this study allows patients to contribute to innovative surgical techniques that may enhance future treatment options.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

Research has shown that both robotic-assisted thoracic surgery (RATS) and video-assisted thoracic surgery (VATS) are safe and effective for treating early-stage lung cancer. Studies have found that both methods achieve similar success rates in curing the disease. Specifically, RATS often results in less blood loss, shorter chest tube duration, and fewer complications compared to other methods. This suggests that the robotic approach is generally well-tolerated by patients undergoing lung surgery. Although some risk accompanies any surgery, evidence indicates that RATS is generally safe for patients.¹²³⁴⁵

Researchers are excited about the robotic lobectomy for lung cancer because it offers a new way to perform surgery with potentially fewer incisions. Unlike the standard video-assisted thoracoscopic surgery (VATS), this method uses 1 to 4 subcostal ports, which could mean less trauma to the body and quicker recovery times for patients. Additionally, the precision of robotic assistance may enhance the surgeon's ability to navigate complex procedures, potentially improving outcomes and reducing complications.

Research has shown that robotic-assisted lobectomies, surgeries to remove part of the lung, can lead to better outcomes for lung cancer patients. Studies have found that these surgeries often cause less pain and allow for quicker recovery compared to traditional methods. Specifically, one study found that patients experienced improved well-being and a higher quality of life six weeks post-surgery. Additionally, robotic lobectomies are associated with fewer complications and better long-term survival rates. In this trial, participants will undergo the "Out of the Cage Robotic Lobectomy," which follows the standard steps of VATS/RATS lobectomy with specific modifications to the incisions. Overall, this technique appears to be a promising option for treating early-stage lung cancer.¹³⁶⁷⁸